Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein

被引:408
作者
Harper, JD
Lieber, CM
Lansbury, PT
机构
[1] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA
[2] MIT, Dept Chem, Cambridge, MA 02139 USA
[3] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
来源
CHEMISTRY & BIOLOGY | 1997年 / 4卷 / 12期
关键词
Alzheimer's disease; amyloid; atomic force microscopy; nucleation; protofibril seeding;
D O I
10.1016/S1074-5521(97)90303-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Amyloid plaques composed of the fibrillar form of the amyloid-beta protein (A beta) are the defining neuropathological feature of Alzheimer's disease (AD). A detailed understanding of the time course of amyloid formation could define steps in disease progression and provide targets for therapeutic intervention. Amyloid fibrils, indistinguishable from those derived from an AD brain, can be produced in vitro using a seeded polymerization mechanism. In its simplest form, this mechanism involves a cooperative transition from monomeric A beta to the amyloid fibril without the buildup of intermediates. Recently, however, a transient species, the A beta amyloid protofibril, has been identified. Here, we report studies of A beta amyloid protofibril and its seeded transition into amyloid fibrils using atomic force microscopy. Results: Seeding of the protofibril-to-fibril transition was observed. Preformed fibrils, but not protofibrils, effectively seeded this transition. The assembly state of A beta influenced the rate of seeded growth, indicating that protofibrils are fibril assembly precursors, The handedness of the helical surface morphology of fibrils depended on the chirality of A beta, Finally, branched and partially wound fibrils were observed. Conclusions: The temporal evolution of morphologies suggests that the protofibril-to-fibril transition is nucleation-dependent and that protofibril winding is involved in that transition. Fibril unwinding and branching may be essential for the post-nucleation growth process. The protofibrillar assembly intermediate is a potential target for AD therapeutics aimed at inhibiting amyloid formation and AD diagnostics aimed at detecting presymptomatic disease.
引用
收藏
页码:951 / 959
页数:9
相关论文
共 32 条
[11]   AGGREGATION STATE AND NEUROTOXIC PROPERTIES OF ALZHEIMER BETA-AMYLOID PEPTIDE [J].
HOWLETT, DR ;
JENNINGS, KH ;
LEE, DC ;
CLARK, MSG ;
BROWN, F ;
WETZEL, R ;
WOOD, SJ ;
CAMILLERI, P ;
ROBERTS, GW .
NEURODEGENERATION, 1995, 4 (01) :23-32
[12]   THE CARBOXY TERMINUS OF THE BETA-AMYLOID PROTEIN IS CRITICAL FOR THE SEEDING OF AMYLOID FORMATION - IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMERS-DISEASE [J].
JARRETT, JT ;
BERGER, EP ;
LANSBURY, PT .
BIOCHEMISTRY, 1993, 32 (18) :4693-4697
[13]   Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease [J].
Lansbury, PT .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (02) :260-267
[14]   A reductionist view of Alzheimer's disease [J].
Lansbury, PT .
ACCOUNTS OF CHEMICAL RESEARCH, 1996, 29 (07) :317-321
[15]   Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation [J].
Lemere, CA ;
Blusztajn, JK ;
Yamaguchi, H ;
Wisniewski, T ;
Saido, TC ;
Selkoe, DJ .
NEUROBIOLOGY OF DISEASE, 1996, 3 (01) :16-32
[16]   REVERSIBLE INVITRO GROWTH OF ALZHEIMER-DISEASE BETA-AMYLOID PLAQUES BY DEPOSITION OF LABELED AMYLOID PEPTIDE [J].
MAGGIO, JE ;
STIMSON, ER ;
GHILARDI, JR ;
ALLEN, CJ ;
DAHL, CE ;
WHITCOMB, DC ;
VIGNA, SR ;
VINTERS, HV ;
LABENSKI, ME ;
MANTYH, PW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5462-5466
[17]   ULTRASTRUCTURAL MORPHOLOGY OF AMYLOID FIBRILS FROM NEURITIC AND AMYLOID PLAQUES [J].
MERZ, PA ;
WISNIEWSKI, HM ;
SOMERVILLE, RA ;
BOBIN, SA ;
MASTERS, CL ;
IQBAL, K .
ACTA NEUROPATHOLOGICA, 1983, 60 (1-2) :113-124
[18]   ULTRASTRUCTURE OF AMYLOID FIBRILS IN ALZHEIMERS-DISEASE AND DOWNS-SYNDROME [J].
MIYAKAWA, T ;
WATANABE, K ;
KATSURAGI, S .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1986, 52 (02) :99-106
[19]  
Naiki H, 1996, LAB INVEST, V74, P374
[20]  
NAIKI H, 1991, LAB INVEST, V65, P104